Similar articles

• Chapter 5. Legal implications of ICD therapy.

  Dickens BM. Dickens BM. Can J Cardiol. 2000 Oct;16(10):1319-24. Can J Cardiol. 2000. PMID: 11064308 No abstract available.
• Implantable cardioverter/defibrillator therapy: the meaning of terms.

  Smith ER. Smith ER. Can J Cardiol. 2000 Oct;16(10):1325-6. Can J Cardiol. 2000. PMID: 11064309 No abstract available.
• Downward delegation of implantable cardioverter defibrillator decision-making in a restricted-resource environment: the pitfalls of bedside rationing.

  Simpson CS, Hoffmaster B, Dorian P. Simpson CS, et al. Can J Cardiol. 2005 May 15;21(7):595-9. Can J Cardiol. 2005. PMID: 15940358 Review.
• Economic analysis of a randomized trial of biventricular pacing in Canada.

  Bentkover JD, Dorian P, Thibault B, Gardner M. Bentkover JD, et al. Pacing Clin Electrophysiol. 2007 Jan;30(1):38-43. doi: 10.1111/j.1540-8159.2007.00577.x. Pacing Clin Electrophysiol. 2007. PMID: 17241313
• Costs and quality-of-life effects of implantable cardioverter-defibrillators.

  Groeneveld PW, Matta MA, Suh JJ, Heidenreich PA, Shea JA. Groeneveld PW, et al. Am J Cardiol. 2006 Nov 15;98(10):1409-15. doi: 10.1016/j.amjcard.2006.06.041. Epub 2006 Oct 4. Am J Cardiol. 2006. PMID: 17134641 Review.